It has been reported that Cu dysregulation instigates and aggravates tau hyperphosphorylation and amyloid plaque formation, eventually leading to synaptic failure, neuronal death, and cognitive decline observed in AD patients [45, 46]. The gene discussed is MAPT; the disease is Alzheimer disease.